康泰生物近况交流

Summary of Conference Call Company Overview - The conference call involved Kangtai Biological, a company in the biopharmaceutical industry, with a focus on recent operational updates and investor engagement [1]. Core Points and Arguments - Introduction by Management: Wu Hua, the IR Director of Kangtai Biological, was present to provide insights into the company's recent developments and operational status [1]. - Structure of the Call: The call was divided into two segments: an introductory presentation by Wu Hua followed by an open Q&A session for investors [1]. Other Important Content - Investor Engagement: The format of the call emphasized transparency and direct communication with investors, indicating the company's commitment to stakeholder engagement [1].